MCH-Guard: Multimodal Machine Learning Framework for Risk Stratification of Cerebral Microhemorrhage Risk in the Alzheimer's Disease Neuroimaging Initiative
Gel, A.; Phillips, E.; Hausle, I.; Thropp, P.; Tosun, D.
Show abstract
Background: Efficient cerebral microhemorrhage (MCH) monitoring is critical for anti-amyloid therapy safety due to ARIA-H risk. We developed MCH-Guard, a multimodal machine-learning framework, to stratify MCH risk using ADNI data (N=813). Methods: Nested models integrated clinical history, fluid biomarkers, and imaging to predict MCH presence, incidence, and stability. Results: The comprehensive model detected baseline MCH with high accuracy (AUC 0.86). Notably, the "minimal" model (M1), utilizing only demographics and clinical history, achieved robust performance (AUC 0.82). Longitudinal models predicted time-to-onset (R2=0.68) and stratified four-year risk. Furthermore, we identified a transient vascular instability phenotype, where MCH status fluctuate, which was strongly predicted by hepatic factors. Conclusions: MCH-Guard offers a flexible clinical decision-support tool for optimizing spontaneous MCH & ARIA surveillance. The strong performance of the clinical-only M1 model supports equitable risk assessment in resource-limited settings, while the characterization of vascular instability addresses a critical confounder in safety monitoring.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease 95%
- Perivascular space enlargement accelerates with hypertension, white matter hyperintensities, chronic inflammation, and Alzheimer’s disease pathology: evidence from a three-year longitudinal multicentre study 95%
- Machine learning applications in vascular neuroimaging for the diagnosis and prognosis of cognitive impairment and dementia: a systematic review and meta-analysis 94%
Similar papers in this journal
- The circulating proteome and brain health: Mendelian randomisation and cross-sectional analyses 95%
- Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset 95%
- Exome-wide age-of-onset analysis reveals exonic variants in ERN1, TACR3 and SPPL2C associated with Alzheimer's disease 93%
Similar papers in this journal
- Cortical microstructural associations with CSF amyloid and pTau 95%
- Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease 94%
- Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies 94%